58-55-9
- Product Name:Theophylline Anhydrous
- Molecular Formula:C7H8N4O2
- Purity:99%
- Molecular Weight:180.166
Product Details:
CasNo: 58-55-9
Molecular Formula: C7H8N4O2
Appearance: white to light yellow crystal powder
Factory Supply High Purity Theophylline Anhydrous 58-55-9 Low Price
- Molecular Formula:C7H8N4O2
- Molecular Weight:180.166
- Appearance/Colour:white to light yellow crystal powder
- Vapor Pressure:2.72E-06mmHg at 25°C
- Melting Point:271-273 °C
- Refractive Index:1.737
- Boiling Point:454.091 °C at 760 mmHg
- PKA:8.77(at 25℃)
- Flash Point:228.426 °C
- PSA:72.68000
- Density:1.466 g/cm3
- LogP:-1.03970
Theophylline Anhydrous (Cas 58-55-9) Usage
Chemical Structure and Derivatives |
Theophylline is a methylxanthine alkaloid and a xanthine derivative. |
Description |
Theophylline Anhydrous is a xanthine derivative medication used in the treatment of respiratory diseases, particularly for chronic therapy. It acts as a weak bronchodilator, helping to alleviate symptoms associated with various lung conditions. |
Chemical Properties |
white to light yellow crystal powder |
Uses | Theophylline Anhydrous is indicated for the management of asthma, a chronic inflammatory condition characterized by airway obstruction, inflammation, and bronchospasm. It is used to manage the reversible component of airway obstruction associated with chronic obstructive pulmonary disease (COPD). |
Brand and Availability | Uniphyl (Theophylline, Anhydrous) is a bronchodilator medication previously available under the brand name Uniphyl. |
InChI:InChI=1/C7H10N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3-5H,1-2H3,(H,8,9)
58-55-9 Relevant articles
Coordination polymers as potential solid forms of drugs: Three zinc(ii) coordination polymers of theophylline with biocompatible organic acids
Lou, Benyong,He, Fengdan
, p. 309 - 316 (2013)
The biocompatible organic acids such as ...
Sleep Quality and Nocturnal Respiratory Function With Once-Daily Theophylline (Uniphyl) and Inhaled Salbutamol in Patients With COPD
Godfrey C.W. Man MB, BS, FCCP a, Kenneth R. Chapman MD, FCCP b, S. Habib Ali PhD c, Andrew C. Darke PhD c
, Chest, Volume 110, Issue 3, September 1996, Pages 648-653
We conclude that, compared with salbutamol, evening administration of once-daily theophylline results in better nocturnal oxygen saturation and an improvement in the overnight change in pulmonary function, without affecting sleep architecture, in patients with COPD.
Inhibition of radical-induced DNA strand breaks by water-soluble constituents of coffee: Phenolics and caffeine metabolites
Rathod,Patel,Das,Tipparaju,Shinde,Anderson, Robert F.
, p. 480 - 487 (2013)
Epidemiological studies have associated ...
SERS multiplexing of methylxanthine drug isomersviahost-guest size matching and machine learning
Chio, Weng-I Katherine,Dinish, U. S.,Jones, Tabitha,Lee, Tung-Chun,Liu, Jia,Olivo, Malini,Parkin, Ivan P.,Perumal, Jayakumar
supporting information, p. 12624 - 12632 (2021/10/06)
Multiplexed detection and quantification...
Polymorphism in Anhydrous Theophylline—Implications on the Dissolution Rate of Theophylline Tablets
Neelima V. Phadnis, Raj Suryanarayanan
, Journal of Pharmaceutical Sciences Volume 86, Issue 11, November 1997, Pages 1256-1263
I* was prepared by dehydration of theophylline monohydrate (II). Variable temperature X-ray powder diffractometry of II revealed the following series of transitions: II → I* → I. The metastable anhydrate, I*, which has not yet been reported in the literature, appears to be related monotropically to I.
58-55-9 Process route
- 58-08-2,138455-22-8,95789-13-2
3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
- 58-55-9,75448-53-2
theophylline
- 83-67-0
theobromine /
- 611-59-6
paraxanthine
- 5415-44-1
1,3,7-trimethyluric acid
Conditions | Yield |
---|---|
With phosphate buffer; NADPH; recombinant rat cytochrome P450 1A2; at 37 ℃; Further Variations:; Catalysts; Enzyme kinetics;
|
|
With NADPH; human cDNA-expressed cytochrome P450 1A2 (supersomes); In phosphate buffer; at 37 ℃; for 60h; pH=7.4; Further Variations:; Reagents; Enzyme kinetics;
|
- 58-08-2,138455-22-8,95789-13-2
3,7-dihydro-1,3,7-trimethyl-1H-purine-2,6-dione
- 58-55-9,75448-53-2
theophylline
- 83-67-0
theobromine /
- 611-59-6
paraxanthine
Conditions | Yield |
---|---|
With hepatic cytochrome P450; Enzymatic reaction;
|
12% 7% |
58-55-9 Upstream products
-
290-87-9
1,3,5-Triazine
-
5440-00-6
4,5-Diamino-1,3-dimethyluracil
-
6642-31-5
6-Amino-1,3-dimethylbarbituric acid
-
77287-34-4
formamide
58-55-9 Downstream products
-
519-37-9
7-(2-hydroxyethyl)theophylline
-
5089-89-4
1,3-dimethyl-7-(morpholinomethyl)xanthine
-
603-00-9
proxyphylline
-
19264-77-8
7-[(2-hydroxy-2-phenyl)ethyl]theophylline
Relevant Products
-
Apixaban
CAS:503612-47-3
-
Mirodenafil
CAS:862189-95-5
-
Valbenazine ditosylate intermediate-02
CAS:1026016-83-0